Rowe, S. P., Campbell, S. P., Mana-Ay, M., Szabo, Z., Allaf, M. E., Pienta, K. J., … Gorin, M. A. (2020). Prospective evaluation of PSMA-targeted 18F-DCFPyL PET/CT in men with biochemical failure after radical prostatectomy for prostate cancer. Journal of Nuclear Medicine, 61, 58–61.

Rowe, Steven P., Scott P. Campbell, Margarita Mana-Ay, Zsolt Szabo, Mohamad E. Allaf, Kenneth J. Pienta, Martin G. Pomper, Ashley E. Ross, and Michael A. Gorin. “Prospective evaluation of PSMA-targeted 18F-DCFPyL PET/CT in men with biochemical failure after radical prostatectomy for prostate cancer.” Journal of Nuclear Medicine 61 (2020): 58–61.

Rowe SP, Campbell SP, Mana-Ay M, Szabo Z, Allaf ME, Pienta KJ, et al. Prospective evaluation of PSMA-targeted 18F-DCFPyL PET/CT in men with biochemical failure after radical prostatectomy for prostate cancer. Journal of Nuclear Medicine. 2020;61:58–61.

Rowe, Steven P., et al. “Prospective evaluation of PSMA-targeted 18F-DCFPyL PET/CT in men with biochemical failure after radical prostatectomy for prostate cancer.” Journal of Nuclear Medicine, vol. 61, Society of Nuclear Medicine, 2020, pp. 58–61.

Rowe SP, Campbell SP, Mana-Ay M, Szabo Z, Allaf ME, Pienta KJ, Pomper MG, Ross AE, Gorin MA. Prospective evaluation of PSMA-targeted 18F-DCFPyL PET/CT in men with biochemical failure after radical prostatectomy for prostate cancer. Journal of Nuclear Medicine. Society of Nuclear Medicine; 2020;61:58–61.